Invest investigational quadrivalent meningococcal conjugate vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Invest investigational quadrivalent meningococcal conjugate vaccine, covering 2020-02-18 to 2020-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older [Phase 3]